Key result
The db/db mouse model of type II diabetes exhibited a slower rate of sweat droplet formation compared to controls at 6 months of age.
Why the study?
Does the db/db type II diabetes mouse model exhibit early sensory and autonomic neuropathy compared to controls?
Does the db/db type II diabetes mouse model exhibit early sensory and autonomic neuropathy compared to controls?
Autonomic neuropathy is an early and prominent deficit in the db/db mouse model of type II diabetes, preceding electrophysiological changes in large nerves.
Answers are grounded in this paper and cite their sources.
May inform preclinical models of diabetic autonomic neuropathy; leaves open translation to clinical sudomotor evaluation.
Sensory and autonomic neuropathy affects the majority of type II diabetic patients. Clinically, autonomic evaluation often focuses on sudomotor function yet this is rarely assessed in animal models. We undertook morphological and functional studies to assess large myelinated and small unmyelinated axons in the db/db type II diabetes mouse model. We observed that autonomic innervation of sweat glands in the footpads was significantly reduced in db/db mice compared to control db/+ mice and this deficit was greater compared to reductions in intraepidermal sensory innervation of adjacent epidermis. Additionally, db/db mice formed significantly fewer sweat droplets compared to controls as early as 6 weeks of age, a time when no statistical differences were observed electrophysiologically between db/db and db/+ mice studies of large myelinated sensory and motor nerves. The rate of sweat droplet formation was significantly slower and the sweat droplet size larger and more variable in db/db mice compared to controls. Whereas pilocarpine and glycopyrrolate increased and decreased sweating, respectively, in 6 month-old controls, db/db mice did not respond to pharmacologic manipulations. Our findings indicate autonomic neuropathy is an early and prominent deficit in the db/db model and have implications for the development of therapies for peripheral diabetic neuropathy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2017) studied Type II diabetes and diabetic neuropathy (n=81). db/db genotype (Type II diabetes model) vs. db/+ genotype (control) was evaluated on Rate of sweat droplet formation at 6 months (droplets/min) (p=<0.05). The db/db mouse model of type II diabetes exhibited a slower rate of sweat droplet formation compared to controls at 6 months of age.
Synapse has enriched 10 related papers. Consider them for comparative context: